BAFL 49.25 Increased By ▲ 2.75 (5.91%)
BIPL 22.22 Increased By ▲ 1.07 (5.06%)
BOP 5.55 Increased By ▲ 0.02 (0.36%)
CNERGY 5.09 Increased By ▲ 0.19 (3.88%)
DFML 19.20 Increased By ▲ 0.38 (2.02%)
DGKC 80.80 Increased By ▲ 0.80 (1%)
FABL 33.24 Increased By ▲ 2.39 (7.75%)
FCCL 20.32 Decreased By ▼ -0.07 (-0.34%)
FFL 9.70 Increased By ▲ 0.14 (1.46%)
GGL 13.72 Decreased By ▼ -0.25 (-1.79%)
HBL 121.48 Increased By ▲ 3.53 (2.99%)
HUBC 123.00 Decreased By ▼ -0.80 (-0.65%)
HUMNL 8.03 Increased By ▲ 0.08 (1.01%)
KEL 3.92 Increased By ▲ 0.41 (11.68%)
LOTCHEM 28.30 Decreased By ▼ -0.25 (-0.88%)
MLCF 42.35 Increased By ▲ 0.25 (0.59%)
OGDC 121.40 Increased By ▲ 0.39 (0.32%)
PAEL 19.80 Increased By ▲ 0.96 (5.1%)
PIBTL 5.82 Increased By ▲ 0.12 (2.11%)
PIOC 116.25 Increased By ▲ 2.54 (2.23%)
PPL 110.13 Increased By ▲ 1.78 (1.64%)
PRL 29.58 Increased By ▲ 1.76 (6.33%)
SILK 1.10 Increased By ▲ 0.03 (2.8%)
SNGP 69.28 Decreased By ▼ -0.12 (-0.17%)
SSGC 13.73 Increased By ▲ 0.48 (3.62%)
TELE 8.87 Increased By ▲ 0.08 (0.91%)
TPLP 14.40 Increased By ▲ 0.75 (5.49%)
TRG 90.50 Decreased By ▼ -1.44 (-1.57%)
UNITY 27.50 Increased By ▲ 0.84 (3.15%)
WTL 1.61 Increased By ▲ 0.04 (2.55%)
BR100 6,621 Increased By 77 (1.18%)
BR30 23,552 Increased By 342 (1.47%)
KSE100 64,493 Increased By 575.1 (0.9%)
KSE30 21,493 Increased By 140.8 (0.66%)
World

First doses of J&J COVID-19 vaccine could be available in Europe in April, EU source

  • The official, who is involved in negotiations with vaccine makers and spoke on condition of anonymity, said the J&J shot.
Published January 13, 2021

BRUSSELS: The European Union expects Johnson & Johnson to deliver the first doses of its COVID-19 vaccine in April after approval from the EU drug regulator, a senior EU official told Reuters on Wednesday.

The official, who is involved in negotiations with vaccine makers and spoke on condition of anonymity, said the J&J shot, which is administered in a single dose, could be available from April 1.

Earlier on Wednesday an EU lawmaker said the EU health commissioner had told an internal meeting in the Parliament that Johnson & Johnson was likely to submit an application to the EU drug regulator in February.

Comments

Comments are closed.